Neuroanatomy and Pathology of Sporadic Alzheimer's Disease Prologue

[1]  H. Soininen,et al.  Harmonized diagnostic criteria for Alzheimer's disease: recommendations , 2014, Journal of internal medicine.

[2]  B. Hyman,et al.  Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center. , 2013, Journal of neuropathology and experimental neurology.

[3]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[4]  Murray Grossman,et al.  CSF biomarkers cutoffs: the importance of coincident neuropathological diseases , 2012, Acta Neuropathologica.

[5]  W. Kukull,et al.  Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 , 2012, Journal of neuropathology and experimental neurology.

[6]  Harald Hampel,et al.  Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention , 2011, Progress in Neurobiology.

[7]  Dietmar R. Thal,et al.  Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.

[8]  Richard J. Kryscio,et al.  Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies , 2011, Acta Neuropathologica.

[9]  D. Perl,et al.  Profiles of Alzheimer's disease-related pathology in an aging urban population sample in India. , 2011, Journal of Alzheimer's disease : JAD.

[10]  R. Mayeux,et al.  Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.

[11]  Charles Duyckaerts,et al.  National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.

[12]  Marie-Claude Potier,et al.  Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.

[13]  H. Braak,et al.  Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship , 2009, Journal of neuropathology and experimental neurology.

[14]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[15]  Claire Mount,et al.  Alzheimer disease: progress or profit? , 2006, Nature Medicine.

[16]  P. Hof,et al.  Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population , 1994, Acta Neuropathologica.

[17]  The Value of Cross Sectional Neuroanatomical Studies as a Conceptual Framework for Prospective Clinicopathological Studies , 1997, Neurobiology of Aging.

[18]  H. Braak,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[19]  C. Duyckaerts,et al.  Prevalence, Incidence and Duration of Braak’s Stages in the General Population: Can We Know? , 1997, Neurobiology of Aging.

[20]  R. Stelzmann,et al.  An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde” , 1995, Clinical anatomy.

[21]  J. Morrison,et al.  Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. , 1994, Cerebral cortex.

[22]  B. Reisberg,et al.  The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline. , 1993, Archives of neurology.